Loomis, Sayles & Company
TECH icon

Loomis, Sayles & Company’s Bio-Techne TECH Stock Holding History

Loomis, Sayles & Company’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Sell
223,735
-12,407
-5% -$670K 0.02% 302
2026
Q1 		$12.3M Buy
+236,142
New +$14.2M 0.02% 319
2022
Q4 		– Sell
-2,400
Closed -$170K – 975
2022
Q3 		$170K Sell
2,400
-290,780
-99% -$25.1M ﹤0.01% 486
2022
Q2 		$25.4M Sell
293,180
-1,872
-0.6% -$175K 0.05% 197
2022
Q1 		$31.9M Sell
295,052
-7,164
-2% -$739K 0.04% 218
2021
Q4 		$39.1M Sell
302,216
-2,112
-0.7% -$259K 0.05% 209
2021
Q3 		$36.9M Sell
304,328
-87,500
-22% -$10.6M 0.05% 216
2021
Q2 		$44.1M Buy
391,828
+15,408
+4% +$1.62M 0.05% 184
2021
Q1 		$35.9M Buy
376,420
+476
+0.1% +$43.4K 0.05% 205
2020
Q4 		$29.8M Buy
375,944
+80,160
+27% +$5.81M 0.04% 207
2020
Q3 		$18.3M Buy
295,784
+43,924
+17% +$2.86M 0.03% 246
2020
Q2 		$16.6M Buy
251,860
+67,476
+37% +$4.04M 0.03% 251
2020
Q1 		$8.74M Buy
+184,384
New +$9.22M 0.02% 302

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Loomis, Sayles & Company's TECH Position: Q2 2026 in Review

Loomis, Sayles & Company reduced its Bio-Techne (TECH) stake by 5.3% in Q2 2026, selling an estimated $670K and leaving 223,735 shares worth $15.8M. The position accounts for 0.02% of the portfolio, ranked #302.

Loomis, Sayles & Company first reported a position in TECH in Q1 2020 and has held it in 13 quarters since. The position peaked at $44.1M in Q2 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Loomis, Sayles & Company held 223,735 shares of Bio-Techne worth $15.8M as of Q2 2026.
  • Loomis, Sayles & Company sold 12,407 Bio-Techne shares in Q2 2026, an estimated $670K.
  • Bio-Techne made up 0.02% of Loomis, Sayles & Company's portfolio in Q2 2026, its #302 holding.
  • Loomis, Sayles & Company first reported a position in Bio-Techne in Q1 2020 and has held it in 13 quarters since.
  • Loomis, Sayles & Company's Bio-Techne position peaked at $44.1M in Q2 2021.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.